| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
3,090 |
2,522 |
$3.50M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
9,998 |
8,211 |
$542K |
| 92134 |
|
15,048 |
12,763 |
$136K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,911 |
4,332 |
$118K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,458 |
1,269 |
$54K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
550 |
479 |
$30K |
| J9035 |
Injection, bevacizumab, 10 mg |
571 |
472 |
$27K |
| J3590 |
Unclassified biologics |
728 |
604 |
$26K |
| 92226 |
|
431 |
250 |
$4K |
| 92202 |
|
203 |
171 |
$1K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
53 |
48 |
$716.12 |
| 92225 |
|
24 |
14 |
$177.56 |
| 2026F |
|
2,526 |
2,310 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
4,170 |
3,771 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
5,272 |
4,870 |
$0.00 |
| 2024F |
|
2,526 |
2,310 |
$0.00 |
| 2022F |
|
2,759 |
2,521 |
$0.00 |
| 5010F |
|
1,917 |
1,749 |
$0.00 |
| G8785 |
Blood pressure reading not documented, reason not given |
608 |
562 |
$0.00 |
| 4004F |
|
63 |
58 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
1,958 |
1,784 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
5,355 |
4,886 |
$0.00 |
| 1036F |
|
6,094 |
5,553 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
194 |
175 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
63 |
58 |
$0.00 |
| G8952 |
Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given |
14 |
12 |
$0.00 |
| 4177F |
|
13 |
12 |
$0.00 |